Universal Flu vaccine gets EU and Japanese patents

The European Union and Japan have granted patents to the universal flu vaccine Multimeric-001 (M-001) developed by Israel’s BiondVax.  The ex-Weizmann Institute technology already has patents in the United States, Hong Kong, Australia, China, Russia and Mexico.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *